QA: MANNKIND CORP in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000899460_2019_MANNKIND_CORP.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.010394047308839282, 'aggregate_val': 104694000, 'exp_sum': 103617000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 19402000, 'SellingGeneralAndAdministrativeExpense': 79716000, 'ResearchAndDevelopmentExpense': 8737000, 'remainder_Expenses': -4238000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000899460')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000899460, MANNKIND CORP

  xvar xval
0 AssetsCurrent 81,854,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 25,602,000
3 remainder_Assets 249,000
4 LiabilitiesCurrent 75,241,000
5 LiabilitiesNoncurrent 10,680,000
6 remainder_Liabilities 196,866,000
7 CostOfGoodsAndServicesSold 19,402,000
8 SellingGeneralAndAdministrativeExpense 79,716,000
9 ResearchAndDevelopmentExpense 8,737,000
10 remainder_Expenses -3,161,000
11 remainder_Revenues 27,859,000
12 remainder_NetIncome -10,140,000
13 remainder_ComprehensiveNetIncome -1,000
  yvar yval
0 Assets 107,705,000
1 Liabilities 282,787,000
2 Expenses 104,694,000
3 Revenues 27,859,000
4 StockholdersEquity -175,082,000
5 NetIncome -86,975,000
6 ComprehensiveNetIncome -86,975,500
7 BaseVar 266,593,000
8 EconomicCapitalRatio -1.99

Edgar->Model Mapping

Feature Distribution

Change over Time